SG11201506408TA - Bicyclic compounds - Google Patents
Bicyclic compoundsInfo
- Publication number
- SG11201506408TA SG11201506408TA SG11201506408TA SG11201506408TA SG11201506408TA SG 11201506408T A SG11201506408T A SG 11201506408TA SG 11201506408T A SG11201506408T A SG 11201506408TA SG 11201506408T A SG11201506408T A SG 11201506408TA SG 11201506408T A SG11201506408T A SG 11201506408TA
- Authority
- SG
- Singapore
- Prior art keywords
- bicyclic compounds
- bicyclic
- compounds
- Prior art date
Links
- 125000002619 bicyclic group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
- C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361767531P | 2013-02-21 | 2013-02-21 | |
PCT/US2014/017534 WO2014130752A2 (en) | 2013-02-21 | 2014-02-21 | Bicyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201506408TA true SG11201506408TA (en) | 2015-09-29 |
Family
ID=50272738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506408TA SG11201506408TA (en) | 2013-02-21 | 2014-02-21 | Bicyclic compounds |
Country Status (35)
Country | Link |
---|---|
US (3) | US9115054B2 (en) |
EP (1) | EP2958888B1 (en) |
JP (1) | JP6277210B2 (en) |
KR (1) | KR102242265B1 (en) |
CN (1) | CN105026362B (en) |
AR (1) | AR094851A1 (en) |
AU (1) | AU2014218883B2 (en) |
BR (1) | BR112015019919A2 (en) |
CA (1) | CA2902168C (en) |
CL (1) | CL2015002358A1 (en) |
CY (1) | CY1118641T1 (en) |
DK (1) | DK2958888T3 (en) |
EA (1) | EA025294B1 (en) |
ES (1) | ES2613262T3 (en) |
HK (1) | HK1218111A1 (en) |
HR (1) | HRP20170247T1 (en) |
HU (1) | HUE031626T2 (en) |
IL (1) | IL240613B (en) |
LT (1) | LT2958888T (en) |
MA (1) | MA38425B1 (en) |
MX (1) | MX2015010347A (en) |
MY (1) | MY173990A (en) |
PE (1) | PE20151746A1 (en) |
PH (1) | PH12015501793A1 (en) |
PL (1) | PL2958888T3 (en) |
PT (1) | PT2958888T (en) |
RS (1) | RS55703B1 (en) |
SG (1) | SG11201506408TA (en) |
SI (1) | SI2958888T1 (en) |
SM (1) | SMT201700115B (en) |
TN (1) | TN2015000356A1 (en) |
TW (1) | TWI613182B (en) |
UY (1) | UY35338A (en) |
WO (1) | WO2014130752A2 (en) |
ZA (1) | ZA201506965B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3022176B8 (en) | 2013-07-15 | 2019-12-25 | The Regents of the University of California | Azacyclic constrained analogs of fty720 |
MA40082B1 (en) * | 2014-08-20 | 2019-09-30 | Bristol Myers Squibb Co | New Sphingosine Phosphate Substitution Compound Useful Treatment Disease Rheumatism |
EP3352753A4 (en) | 2015-09-24 | 2019-03-13 | The Regents of The University of California | Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment |
EP3507278B1 (en) | 2016-09-02 | 2021-01-27 | Bristol-Myers Squibb Company | Substituted tricyclic heterocyclic compounds |
US11046646B2 (en) | 2017-08-09 | 2021-06-29 | Bristol-Myers Squibb Company | Alkylphenyl compounds |
US11059784B2 (en) | 2017-08-09 | 2021-07-13 | Bristol-Myers Squibb Company | Oxime ether compounds |
WO2021062168A1 (en) * | 2019-09-25 | 2021-04-01 | The Regents Of The University Of California | Synthetic sphingolipid inspired molecules with heteroaromatic appendages, methods of their synthesis and methods of treatment |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200750A (en) | 1977-01-07 | 1980-04-29 | Westwood Pharmaceuticals Inc. | 4-Substituted imidazo [1,2-a]quinoxalines |
US6069143A (en) | 1994-12-20 | 2000-05-30 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
CA2472680A1 (en) | 2002-01-18 | 2003-07-31 | Merck & Co., Inc. | Selective s1p1/edg1 receptor agonists |
DE60329073D1 (en) | 2002-01-18 | 2009-10-15 | Merck & Co Inc | EDG RECEPTOR AGONISTS |
AU2003202994B2 (en) | 2002-01-18 | 2007-11-22 | Merck Sharp & Dohme Corp. | N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists |
EP1482895A4 (en) | 2002-03-01 | 2005-04-27 | Merck & Co Inc | Aminoalkylphosphonates and related compounds as edg receptor agonists |
EP1549640A4 (en) | 2002-06-17 | 2008-08-06 | Merck & Co Inc | 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
AU2004251146A1 (en) | 2003-05-19 | 2005-01-06 | Irm, Llc | Immunosuppressant compounds and compositions |
EP1697333A4 (en) | 2003-12-17 | 2009-07-08 | Merck & Co Inc | (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
TW200538433A (en) | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
US7659294B2 (en) | 2004-10-22 | 2010-02-09 | Merck & Co., Inc. | 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists |
EP1863463A1 (en) | 2005-02-14 | 2007-12-12 | University Of Virginia Patent Foundation | Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substitued by amino and phenyl groups |
US20060199853A1 (en) | 2005-02-18 | 2006-09-07 | Charles Mioskowski | Analogs of 4-hydroxyisoleucine and uses thereof |
AU2006222563A1 (en) | 2005-03-08 | 2006-09-14 | Biota Scientific Management Pty Ltd. | Bicyclic nucleosides and nucleotides as therapeutic agents |
BRPI0609668A2 (en) | 2005-03-23 | 2011-10-18 | Actelion Pharmaceuticals Ltd | compound, pharmaceutical composition, and use of a compound |
NZ563522A (en) | 2005-04-22 | 2010-01-29 | Daiichi Sankyo Co Ltd | Heterocyclic compound with immunosuppressive activity |
EP1893591A1 (en) | 2005-06-08 | 2008-03-05 | Novartis AG | POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS |
EP1917240A1 (en) | 2005-08-23 | 2008-05-07 | Irm Llc | Immunosuppressant compounds and compositions |
ES2594156T3 (en) | 2006-01-06 | 2016-12-16 | Sunovion Pharmaceuticals Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
CN101378741A (en) | 2006-01-27 | 2009-03-04 | 弗吉尼亚大学专利基金会 | Method for treatment of neuropathic pain |
WO2007088450A2 (en) | 2006-02-01 | 2007-08-09 | Pfizer Products Inc. | Chromane antagonist of the h-3 receptor |
CL2007000742A1 (en) | 2006-03-21 | 2008-01-11 | Epix Delaware Inc | Compounds derived from 2-oxoimidazole, modulators of the s1p receptor (sphingosine-1-phosphate); farm composition that contains them; and its use to treat conditions such as transplant rejection, cancer, rheumatoid arthritis and diabetes. |
WO2007111864A2 (en) | 2006-03-23 | 2007-10-04 | Merck & Co., Inc. | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
AU2007236707C1 (en) | 2006-04-03 | 2012-05-24 | Astellas Pharma Inc. | Hetero compound |
JP2009269819A (en) | 2006-08-25 | 2009-11-19 | Asahi Kasei Pharma Kk | Amine compound |
ES2400163T3 (en) | 2006-09-08 | 2013-04-08 | Actelion Pharmaceuticals Ltd. | Pyridyl-3-yl derivatives as immunomodulation agents |
US8217027B2 (en) | 2006-12-21 | 2012-07-10 | Abbott Laboratories | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
TW200838497A (en) * | 2006-12-21 | 2008-10-01 | Abbott Lab | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
GB0625648D0 (en) | 2006-12-21 | 2007-01-31 | Glaxo Group Ltd | Compounds |
CN101610674A (en) * | 2006-12-21 | 2009-12-23 | 艾博特公司 | Sphingosine-1-phosphate ester receptor stimulating agent and agonist compounds |
KR101275405B1 (en) | 2007-02-02 | 2013-06-17 | 에프. 호프만-라 로슈 아게 | Novel 2-aminooxazolines as taar1 ligands for cns disorders |
SI2125797T1 (en) | 2007-03-16 | 2014-03-31 | Actelion Pharmaceuticals Ltd. | Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
MX2010003612A (en) | 2007-10-04 | 2010-04-30 | Merck Serono Sa | Oxadiazole derivatives. |
KR20100092473A (en) | 2007-11-01 | 2010-08-20 | 액테리온 파마슈티칼 리미티드 | Novel pyrimidine derivatives |
GB0725105D0 (en) | 2007-12-21 | 2008-01-30 | Glaxo Group Ltd | Compounds |
WO2009124022A1 (en) | 2008-04-01 | 2009-10-08 | Theravance, Inc. | 2 -aminotetralin derivatives as mu opioid receptor antagonists |
EP2344446A4 (en) | 2008-10-17 | 2012-04-04 | Akaal Pharma Pty Ltd | S1p receptors modulators |
ES2543205T3 (en) | 2008-12-18 | 2015-08-17 | Merck Serono S.A. | Functional heterocytic derivatives of oxidiazol |
EP2202232A1 (en) | 2008-12-26 | 2010-06-30 | Laboratorios Almirall, S.A. | 1,2,4-oxadiazole derivatives and their therapeutic use |
EP2210890A1 (en) | 2009-01-19 | 2010-07-28 | Almirall, S.A. | Oxadiazole derivatives as S1P1 receptor agonists |
CN102361868A (en) | 2009-01-23 | 2012-02-22 | 百时美施贵宝公司 | Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists |
WO2010085582A1 (en) | 2009-01-23 | 2010-07-29 | Bristol-Myers Squibb Company | Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
EP2382212B1 (en) | 2009-01-23 | 2014-07-16 | Bristol-Myers Squibb Company | Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
CA2750125A1 (en) | 2009-02-10 | 2010-08-19 | Abbott Laboratories | Methods for preparing s1p receptor agonists and antagonists |
US8399451B2 (en) | 2009-08-07 | 2013-03-19 | Bristol-Myers Squibb Company | Heterocyclic compounds |
ES2759949T3 (en) | 2009-10-29 | 2020-05-12 | Bristol Myers Squibb Co | Tricyclic Heterocyclic Compounds |
WO2011133734A1 (en) | 2010-04-23 | 2011-10-27 | Bristol-Myers Squibb Company | 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists |
CN102260178A (en) | 2010-05-25 | 2011-11-30 | 中国医学科学院药物研究所 | Hydroxyl propanediol derivative, its preparation method, its pharmaceutical composition and its purpose |
CN102260177A (en) | 2010-05-25 | 2011-11-30 | 中国医学科学院药物研究所 | Propylene glycol derivative, preparation method thereof, pharmaceutical composition thereof and application thereof |
US8822510B2 (en) | 2010-07-20 | 2014-09-02 | Bristol-Myers Squibb Company | Substituted 3-phenyl-1,2,4-Oxadiazole compounds |
US9187437B2 (en) | 2010-09-24 | 2015-11-17 | Bristol-Myers Squibb Company | Substituted oxadiazole compounds |
WO2012061459A1 (en) | 2010-11-03 | 2012-05-10 | Bristol-Myers Squibb Company | Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases |
EP2685971A2 (en) * | 2011-03-18 | 2014-01-22 | University Of Virginia Patent Foundation | Compositions and methods for tissue engineering and cell based therapies |
EP2541155B1 (en) | 2011-04-26 | 2016-02-24 | Panasonic Intellectual Property Management Co., Ltd. | Heating system, and heating system control method |
GB201107325D0 (en) * | 2011-05-04 | 2011-06-15 | Glaxosmithkline Llc | Novel compounds |
US9481659B2 (en) | 2011-05-13 | 2016-11-01 | Celgene International Ii Sàrl | Selective heterocyclic sphingosine 1 phosphate receptor modulators |
ES2671194T3 (en) | 2012-07-27 | 2018-06-05 | Biogen Ma Inc. | Compounds that are S1P modulating agents and / or ATX modulating agents |
-
2014
- 2014-02-20 UY UY0001035338A patent/UY35338A/en unknown
- 2014-02-20 TW TW103105719A patent/TWI613182B/en not_active IP Right Cessation
- 2014-02-20 US US14/185,164 patent/US9115054B2/en active Active
- 2014-02-21 KR KR1020157025410A patent/KR102242265B1/en active IP Right Grant
- 2014-02-21 CA CA2902168A patent/CA2902168C/en not_active Expired - Fee Related
- 2014-02-21 MX MX2015010347A patent/MX2015010347A/en unknown
- 2014-02-21 LT LTEP14709822.2T patent/LT2958888T/en unknown
- 2014-02-21 MA MA38425A patent/MA38425B1/en unknown
- 2014-02-21 WO PCT/US2014/017534 patent/WO2014130752A2/en active Application Filing
- 2014-02-21 AR ARP140100554A patent/AR094851A1/en unknown
- 2014-02-21 SG SG11201506408TA patent/SG11201506408TA/en unknown
- 2014-02-21 JP JP2015558976A patent/JP6277210B2/en active Active
- 2014-02-21 HU HUE14709822A patent/HUE031626T2/en unknown
- 2014-02-21 PE PE2015001795A patent/PE20151746A1/en active IP Right Grant
- 2014-02-21 DK DK14709822.2T patent/DK2958888T3/en active
- 2014-02-21 SI SI201430106A patent/SI2958888T1/en unknown
- 2014-02-21 CN CN201480009497.1A patent/CN105026362B/en active Active
- 2014-02-21 AU AU2014218883A patent/AU2014218883B2/en not_active Ceased
- 2014-02-21 BR BR112015019919A patent/BR112015019919A2/en not_active Application Discontinuation
- 2014-02-21 EA EA201591409A patent/EA025294B1/en not_active IP Right Cessation
- 2014-02-21 MY MYPI2015702746A patent/MY173990A/en unknown
- 2014-02-21 RS RS20170188A patent/RS55703B1/en unknown
- 2014-02-21 PL PL14709822T patent/PL2958888T3/en unknown
- 2014-02-21 EP EP14709822.2A patent/EP2958888B1/en active Active
- 2014-02-21 PT PT147098222T patent/PT2958888T/en unknown
- 2014-02-21 ES ES14709822.2T patent/ES2613262T3/en active Active
-
2015
- 2015-07-14 US US14/798,498 patent/US9359286B2/en active Active
- 2015-08-14 PH PH12015501793A patent/PH12015501793A1/en unknown
- 2015-08-17 IL IL240613A patent/IL240613B/en active IP Right Grant
- 2015-08-18 TN TN2015000356A patent/TN2015000356A1/en unknown
- 2015-08-21 CL CL2015002358A patent/CL2015002358A1/en unknown
- 2015-09-18 ZA ZA2015/06965A patent/ZA201506965B/en unknown
-
2016
- 2016-05-06 US US15/148,222 patent/US9487481B2/en active Active
- 2016-05-27 HK HK16106055.1A patent/HK1218111A1/en not_active IP Right Cessation
-
2017
- 2017-02-16 HR HRP20170247TT patent/HRP20170247T1/en unknown
- 2017-02-16 CY CY20171100216T patent/CY1118641T1/en unknown
- 2017-02-21 SM SM201700115T patent/SMT201700115B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2958562A4 (en) | Antidiabetic bicyclic compounds | |
AP2015008713A0 (en) | Tetrahydropyrrolothiazine compounds | |
GB201309085D0 (en) | Compounds | |
GB201302927D0 (en) | Compounds | |
GB201310542D0 (en) | Compounds | |
GB201311951D0 (en) | Compounds | |
HK1219472A1 (en) | Bicyclic analgesic compounds | |
GB201309508D0 (en) | Compounds | |
HRP20170247T1 (en) | Bicyclic compounds | |
AP3850A (en) | Azetidinyloxyphenylpyrrolidine compounds | |
GB201317619D0 (en) | Compounds | |
GB201312901D0 (en) | Compounds | |
GB201311953D0 (en) | Compounds | |
EP3010923A4 (en) | Pyrroloquinazoline compounds | |
EP2948457A4 (en) | Compounds | |
GB201316014D0 (en) | Compounds | |
GB201310460D0 (en) | Compounds | |
GB201306794D0 (en) | Compounds | |
GB201318143D0 (en) | Compounds | |
GB201317118D0 (en) | Compounds | |
GB201316717D0 (en) | Compounds | |
GB201315947D0 (en) | Compounds | |
GB201315254D0 (en) | Compounds | |
GB201315253D0 (en) | Compounds | |
GB201314700D0 (en) | Compounds |